Work

PND56 Cost-Effectiveness of Erenumab for the Prevention of Migraine in Portugal

Year: 2020

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2020.08.1381

Authors: C. Silva, S. Monge, P. Cooney, R. Mahon, P.A. Laires

Institutions: Novartis Farma SA (Portugal), Novartis (Ireland)

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3110990649

Cites:

Cited by: 1

Related to: 10